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1. Introduction 
Studying infections caused by the Staphylococcus spp. genus is highly important for human 
health given that such organisms are causal agents of superficial infections, such as 
abscesses and impetigo, as well as of systemic infections, namely bacteremia and 
osteomyelitis. This genus is divided into two large groups. The first group is characterized 
by the production of enzyme coagulase, and its main representative is S. aureus, which is 
frequently associated with a large variety of infections. The second group, known as 
coagulase-negative staphylococci (CoNS), is usually associated with immunocompromised 
patients or those who use catheters. (Kloos & Bannerman, 1995). The main CoNS species 
associated with infection in humans are S. epidermidis, S. haemolyticus, S. saprophyticus, S. 
cohnii, S. xylosus, S. capitis, S. warneri, S. hominis, S. simulans, S. saccharolyticus, S. auricularis, 
S. caprae, S. lugdunensis and S. schleiferi (Kloos & Bannerman, 1995).  
Several studies have reported increased prevalence of CoNS infection in hospitals, which is 
usually associated with resistance to the antibiotic of choice for treatment. Hence, this is a 
serious clinical and epidemiological problem (Jain et. al., 2008). 
The use of methicillin and other semi-synthetic penicillins, such as oxacillin and 
penicillinase-resistant methicillin, which began in 1959, represented a significant phase in 
anti-staphylococcal therapy. The first report on methicillin resistance was in 1961, a short 
time after its use was implemented (Hiramatsu et al, 2001). In Brazil, it is estimated that the 
frequency of oxacillin resistance is high among S. aureus samples, particularly in large and in 
university hospitals. Gales (2009) described an oxacillin resistance rate of 31% in a multi-
center study involving four Brazilian hospitals. As regards CoNS, 78.7% of the samples were 
resistant. At the Botucatu School of Medicine University Hospital – SP, approximately 45% 
of the S. aureus samples from hemocultures were positive for the mecA gene (Martins et al., 
2010). In a study conducted at the neonatal intensive care unit of the same hospital, a total of 
18% of MRSA samples was found (Pereira et al., 2009).  According to a study by Sader et al. 
(2004) in Latin America and Brazil, respectively, 80.4% and 84.6% of the CoNS samples from 
hemocultures were oxacillin resistant.  
Oxacillin resistance in CoNS samples varies significantly among the different species in the 
genus, a fact that reinforces the importance of their correct identification (Secchi et al., 2008). 
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Although S. epidermidis is the most frequently found species (Vuong & Otto, 2002),  
others are also associated with human infection, such as S. haemolyticus, which can be multi-
resistant and present intermediate resistance to vancomycin (Secchi et al., 2008). The  
main resistance mechanism is the presence of the mecA gene, inserted in the chromosomal 
cassette, known as staphylococcal chromosomal cassette mec (SCCmec). The detection of  
this gene and the typing of the chromosomal cassette by means of various molecular 
methods are important tools for the diagnosis and epidemiology of oxacillin-resistant 
Staphylococcus spp. 
There are eleven SCCmec types, with subtypes, which are characterized by molecular tools, 
such as Multilocus Sequence Typing (MLST), pulsed-field gel electrophoresis (PFGE), spa 
typing and Multiplex PCR for SCCmec detection. They are useful in the characterization and 
detection of alterations in molecular structure.  By using these methods, it was possible to 
identify pandemic clones as well as to characterize strains causing outbreaks in hospitals. 
Among these methods, the MLST is noteworthy due to its high reproducibility and capacity 
of detecting pandemic clones. Given the fact that vancomycin is a therapeutic option for 
oxacillin-resistant samples, with the emergence of vancomycin-resistant Staphylococcus spp., 
the characterization of circulating strains and clones is highly important. This chapter aimed 
at addressing aspects related to the molecular epidemiology in Staphylococcus spp. since 
these microorganisms have been increasingly frequent as agents of nosocomial and 
community infection. 
2. Epidemiological aspects 
Oxacillin resistance in CoNS is a problem in hospitals around the world, and there are reports 
of oxacillin-resistant samples in all continents (Witte, 1999).  The use of methicillin, a semi-
synthetic penicillin, commenced in 1959, and only two years after its first use, the first report of 
a methicillin-resistant Staphylococcus spp. sample was published (Hiramatsu et al., 2001). 
Oxacillin resistance rates vary among various studies, but they are usually high, above 50%. 
Chaudhury & Kumar (2007) reported that, in a study conducted in a tertiary Indian hospital, 
64.6% of the CoNS samples were oxacillin resistant. The most prevalent species was S. 
haemolyticus, isolated from urine samples. Another study also performed in India, described 
resistance levels of approximately 63% (Jain et al., 2008).  
In the European continent, several reports described high oxacillin resistance levels in 
hospital wards. In a study analyzing samples collected from various hospitals in Eastern 
Europe in 2005, Sader et al. (2007) reported oxacillin resistance levels in CoNS which varied 
from 54.8% in Sweden to 83.3% in Greece. A study conducted at a university hospital in 
Turkey found 54.4% of resistant samples from a total of 158 isolated samples (Ercis et al., 
2008). The rates found by a multi-center study conducted in the USA in 2007 and 2008 were 
of 74% of CoNS oxacillin-resistant samples (Sader & Jones, 2009).  
Nevertheless, in the last few years, resistance levels have stabilized. In Spain, a multi-center 
study on 146 hospitals detected oxacillin resistance in 61.3% of the samples in 2002 and 
66.7% in 2006 (Cuevas et al., 2008). In Brazil, recent studies showed resistance rates of 69% 
(Caierão et al., 2004), 78.4% (Perez & d'Azevedo 2007) and even 88.1% (Antunes et al., 2007). 
In the case of non-epidermidis CNS, Secchi et al. (2008) reported 71% of resistant samples. 
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Based on the described reports, it is clear that oxacillin resistance is prevalent in hospital in 
all continents, a fact that reinforces the importance of good antibiotic therapy practices and 
of infection control measures in hospitals.  
3. Oxacillin resistance 
Oxacillin resistance is associated with the drug’s reduced capacity to adhere to the 
penicillin-binding protein (PBP), thus also losing its capacity to lyse the bacterial cell. There 
are three mechanisms of resistance to semi-synthetic penicillinases, a group of drugs in 
which oxacillin is included. The first is related to the hyperproduction of β-lactamases, 
enzymes that cleave the drug’s β-lactam ring, thus inactivating it (McDougal & Thornsberry, 
1986). The second mechanism, known as MOD-SA, occurs when normal PBPs have reduced 
affinity with oxacillin (Tomasz et al., 1989). The third and most important mechanism is the 
presence of the mecA gene. This gene codifies a changed PBP, known as PBP 2a, thus 
preventing its binding to oxacillin (Zhang et al., 2009).  
Although resistance mediated by the mecA gene is present in all cells of the population with 
intrinsic resistance, it can only be expressed by a small percentage of such cells, thus leading 
to the so-called heterogeneous resistance.  Resistance expression in lineages with intrinsic 
resistance has been categorized into four phenotypic classes; classes 1 to 4, in which class 1 is 
the most heterogeneous and class 4 is the homogeneous one (Tomacz et al., 1991). The 
majority of cells (99.9 or 99.99%) in the culture of lineages with class-1 heterogeneous 
resistance show minimum inhibitory concentration (MIC) of 1.5 to 3 g/ml, but such culture 
also contains a small number of bacteria (10-7 to 10-8) that could form colonies even in the 
presence of 25 g/ml or more of oxacillin. In class-2 lineage cultures, the majority of cells ( 
99.9%) show MIC of 6 to 12 g/ml, and in these cultures, the frequency of highly resistant 
cells (capable of growing in the presence of 25 g/ml) is higher (10-5) than in class-1 lineages 
(Tomacz et al. , 1991). Class-3 lineage cultures consist of bacteria (99 to 99,9%) that show 
high levels of oxacillin resistance (MIC = 50 to 200 g/ml), but they usually have a 
subpopulation (10-3) of highly resistant cells that are capable of forming colonies even in the 
presence of 300 to 400 g de oxacillin/ml. Class-4 cultures comprise cells with homogeneous 
resistance, with all cells showing high resistance levels and MIC of 400 to 1,000 g/ml 
(Tomacz et al., 1991).  
The phenotypic expression codified by the mecA gene is affected by various factors, 
including pH, temperature and osmolarity (Swenson, 2002). When proper conditions are 
used for laboratory MRSA detection, including Mueller-Hinton agar supplementation with 
NaCl and adequate temperature and time, as recommended by CLSI (Clinical and 
Laboratory Standards Institute), detection is achieved without much difficulty. However, for 
more heterogeneous lineages, detection can be more difficult, even with reference methods 
(Swenson, 2002). 
Adequate detection of oxacillin resistance mediated by the mecA gene is important for 
clinical laboratories. Although the recommended methods detect most of the oxacillin-
resistant lineages, there are two situations that require additional phases to confirm 
sensitivity or resistance. The first is the occurrence of extremely heterogeneous lineages that 
are found to be sensitive by reference methods. The second is the occurrence of borderline 
resistance (MIC close to the sensitivity breakpoint), which must be differentiated from 
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resistance mediated by the mecA gene as long as the clinical significance of the resistance 
determined by the mecA gene is greater.  
The mecA gene is inserted in a transposable genetic element known as Staphylococcal 
Chromosomal Cassette mec (SCCmec). This element varies in its constitution and is divided 
into eleven types. The typing of SCCmec types is useful as an epidemiological tool 
(Mombach Pinheiro Machado et al., 2007) given that the different types are more prevalent 
in hospital and community environments. The SCCmec types (IWG-SCC, 2009) differ from 
one another in relation to the number of genes that they carry in their gene architecture 
(Hiramatsu et al., 2001). Some of these types are carriers of resistance genes that are 
determinant for multiple antibacterial drugs. In addition to beta-lactam antibiotics, 
macrolides, lincosamides, streptogramins, aminoglycosides and tetracycline are noteworthy. 
Hence, when a bacterial cell acquires such SCCmec, it at once acquires a multiple-resistance 
phenotype (Ito et al., 2003). 
The SCCmec types have been defined by the combination of two parts: the ccr complex and 
the mec complex, with three phylogenetically distinct ccr genes classified as: ccrA, ccrB and 
ccrC.  Additionally, there are five classes of mec gene complexes (classes A, B, C1, C2 and 
class D) (Ito et al., 2004; IWG-SCC, 2009). The different SCCmec types are classified as: type-I 
SCCmec (class B and ccrA1B1 mec gene complex), type-II SCCmec (class A and ccrA2B2 mec 
gene complex), type-III SCCmec (class A and ccrA3B3 mec gene complex), type-IV SCCmec 
(class B and ccrA2B2 mec gene complex), type-V SCCmec (class C2 and ccrC mec gene 
complex), type-VI SCCmec (class B and ccrA4B4 mec gene complex), type-VII SCCmec (class 
C1 and ccrC mec gene complex) and type-VIII SCCmec (class A and ccrA4B4 mec gene 
complex). The remaining region of SCCmec is called the J region (Joining region), which 
constitutes non-essential components of the cassette that can carry additional antimicrobial 
resistance determinants (Hanssen & Sollid, 2006; IWG-SCC, 2009). Recently, types IX (class 
C2, ccr1 mec gene complex), X (class C1, ccr7 mec gene complex) and XI (class E, ccr8 mec 
gene complex) have been described (IWG-SCC, 2011) (Table 1).  
 
SCCmec type mec gene complex ccr gene complex 
I 
II 
III 
IV 
V 
VI 
VII 
VIII 
IX 
X 
XI 
B 
A 
A 
B 
C2 
B 
C1 
A 
C2 
C1 
E 
1 (A1B1) 
2 (A2B2) 
3 (A3B3) 
2 (A2B2) 
5 (C1) 
4 (A4B4) 
5 (C1) 
4 (A4B4) 
1 (A1B1) 
7 (A1B6) 
8 (A1B3) 
Source: http://www.sccmec.org/Pages/SCC_TypesEN.html. Accessed on 06/20/2011 
Table 1. SCCmec types identified in S.aureus 
The first three types were detailed by Ito et al. in 2001, and the same author also reported 
and described type V in 2004. Ma et al. (2002) described type IV, which is mainly found in 
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community samples. Types I, II and III are mainly responsible for nosocomial infections, 
and they are significantly larger than the last types IV and V. Type-I cassette was described 
with a size of 34.364 bp, and it is the largest of the three. This cassette does not feature any 
inserted transposons or plasmids that provide resistance to other drugs besides methicillin 
or to heavy metals. It has a sub-type known as IA, which differs from type I for having an 
integrated plasmid, pUB110 (Shore et al., 2005). 
The second cassette, referred to as II, has 53.017 bp, and in addition to the mecA and mecRI 
genes, which cause methicillin resistance, it contains transposon Tn 554. The latter is 
responsible for the resistance of this sample type to erythromycin and streptomycin. This 
cassette has a sub-type that is referred to as IIA, with a size of 40 Kb, thus being a little 
smaller than type II (Shore et al., 2005). 
Type-III cassette, the largest of the five types, has a size of 66.896 bp and contains genes 
mecA, mecRI, transposons Tn 554 and Tn 554 and plasmid pt 181. Transposon Tn 554 
induces cadmium resistance, and plasmid pt 181 is responsible for tetracycline and mercury 
resistance. In addition to the information described above, the authors also mentioned 
differences between the ccr gene types, by describing, in type-III SCCmec, a gene that is not 
present in the other types and is referred to as ccr. They also suggested that some of the 
resistance characteristics in type III can be used as selective markers. This cassette type 
presents two sub-types: IIIA, which does not have plasmid pt 181 and flanks with element IS 
431, and IIIB, where there are no copies of plasmids pt 181 or tn 554 (Shore et al., 2005). 
Type-IV SCCmec is mainly responsible for community infections. It is a small element that 
does not carry other resistance genes, except for mecA. It is also divided into multiple sub-
types, which suggests that type-IV SCCmec is highly transmittable (Ito et al., 2004). The four 
sub-types of type-IV, -IVA, -IVB, -IVC and -IVD cassettes differ for presenting different 
sequences on the left extremity of the ccr complex, which is known as L – C Region (Shore et 
al., 2005). 
Type-V SCCmec was identified by Ito et al. (2004) in an Australian isolate. It has the size of 
27.624 bp, and it is a little larger than SCCmec IV although smaller than the other existing 
types. Similarly to type IV, it has only genes that codify methicillin resistance; however, 
differently from the other elements in this family, type V has a new ccr gene type that is 
characterized as type c and is individually found, contrarily to other elements, which have a 
pair of such genes. Another new element found only in type V is a restriction and 
modification system codified by genes V22 and V23. Recent studies associate the presence of 
this mec cassette type with community infections (O’Brien et al., 2005; Ho et al., 2007). 
Oliveira et al. (2006) characterized type-VI SCCmec, which is found in samples belonging to 
the pediatric clone of MRSA (Methicillin Resistant S.aureus) samples and previously typed 
as SCCmec IV. The authors described differences in the ccrAB complex, identified as type 4, 
and the presence of the type-B mec complex, which does not have the mecl gene. 
Type-VII SCCmec was identified by Higuchi et al. (2008) through a detailed analysis of 
community S.aureus samples isolated in Taiwan. It has a size of 41.347 bp, and its mec 
complex is homologous to that found in type V, but presents substitutions, insertions and 
rearrangements that differentiate it. The main characteristics of this cassette type are the 
presence of the ccrC complex, of transposon ΨIS431 and of a unique sequence on the right 
side of the cassette which is referred to as orf35. 
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Recently, Zhang et al. (2009) have described a new SCCmec type which has been 
denominated as SCCmec VIII and was found in an MRSA sample from a hospital. This new 
cassette has a size of 32.168 base pairs, and genes mecA mecR1 mecI of the mec complex and 
ccrA4 ccrB4 of the ccr complex are present in addition to transposon Tn554, which is also 
present in type II. 
4. Molecular epidemiology  
In addition to the characterization of SCCmec types as an epidemiological tool, other 
methods are available for molecular epidemiology studies, such as Pulsed Field Gel 
Electrophoresis (PFGE), Multilocus Sequence Typing (MLST) and spa typing, which allow 
for the identification of circulating bacterial clones in hospitals and in the community.  
PFGE is a method that uses restriction enzymes to cleave the extracted DNA, and in the case 
of the Staphylococcus genus, the enzyme used is SmaI. The fragments are separated in 
agarose gel. The direction of the electrical field is periodically changed, forming a 120º angle. 
This allows for fragments of up to 12mb to be separated, contrarily to conventional 
electrophoresis, which is not capable of separating fragments that are larger than 50kb 
(Herschleb et al., 2007). This method is generally used in local studies, such as in hospital 
outbreaks, which allows for identifying the circulating type.  
The sequencing of constitutive bacterial genes can also be used as an important 
epidemiological tool. The method known as spa typing investigates polymorphisms on a 
single locus. It can discriminate between PFGE and MLST and is also applied in local studies 
and for detecting pandemic clones (Malachowa et al., 2005). 
Another methodology that uses the sequencing and analysis of genetic polymorphisms is 
MLST. It analyzes the sequence of seven constitutive genes (gmk, pta, dfp, gtr, mutS, pyrR, 
and xpt) and compares them with the sequences of each allele in the locus, which are 
previously numbered. The combination of the alleles identified in each gene determines the 
profile of the sample. (Aanensen & Spratt, 2005). It is the most adequate methodology for 
detecting pandemic clones given that the investigated genes are constitutive, with low 
mutation rates when compared to the analysis of the whole chromosome, in the case of 
PFGE (Miragaia et al., 2007). 
5. Pandemic clones of MRSA samples 
Currently, Staphylococcus spp. samples have been typed in numerous epidemiological studies 
by means of the methods described above. By using these tools, 05 large pandemic clones 
have been described. These are the Brazilian clone, characterized by SCCmec IIIA, MLST 2-3-
1-4-4-3 (ST 239); the Iberian clone with type-IA SCCmec, and MLST 3-3-1-1/12-4-4-16 (ST 
247); the clone known as New York / Japan, with type-III SCCmec, pattern MLST 1-4-1-4-12-
1-10 (ST 05); the Hungarian clone, with SCCmec III, MLST 2-3-1-1-4-4-3 (ST 239); the 
pediatric clone, with type-IV SCCmec, MLST 1-4-1-4-12-1-10 (ST 05) and the last large clone 
known as EMRSA-16, SCCmec II MLST 15-12-16-02-16-02-25-17-24-24-24 (ST 36) (Oliveira et 
al., 2002; Melter et al., 2003; Velásquez-Meza et al. 2004; Aires de Souza & De Lencastre, 
2004, Aires Ribeiro et al., 2005). 
In our scenario, the predominant MRSA samples belong to the Brazilian clone (Oliveira et 
al., 2001). The first report on the emergence of this clone dates to 1992-93 in various hospitals 
www.intechopen.com
Epidemiological Aspects of Oxacillin-Resistant  
Staphylococcus spp.: The Use of Molecular Tools with Emphasis on MLST 
 
101 
in Brazil. The samples were characterized as belonging to the same clone by methods such 
as PFGE and by showing patterns of transposon Tn554 and the polymorphism of the mecA 
gene (Teixeira et al., 1995). In other countries, the Brazilian clone is also disseminated, as is 
the case of the Czech Republic, where the isolation of this clone represented 80% of the 
MRSA samples found in 1996-1997 (Melter et al., 2003).  The Brazilian clone was also 
described in India, in two hospitals in the region of Bengalore, conjointly with the 
Hungarian clone (SCCmec III) (Arakere et al., 2005)  
Other clones are distributed in several parts of the world. The Iberian clone was firstly 
described in samples from hospitals in Barcelona and Madrid, Spain, and in Lisbon, 
Portugal. These samples were typed by the PFGE method and probe hybridization, 
producing a pattern that characterized them as belonging to the same clone. This clone is 
also described in other countries, such as the Czech Republic (Melter et al., 2003). The clone 
known as New York – Japan, firstly isolated in the USA in 1994-98 and in Japan in 1997-98 
(Oliveira et al., 2002), was also predominant in Mexico during a study on 98 MRSA samples, 
thus replacing the local clone, known as Mexican (PFGE M, type-IV SCCmec), in nosocomial 
infections (Velasquez-Meza et al., 2004).  
The Hungarian clone, firstly identified in Hungary in 1993-94, was characterized by the 
same methods used for the clones described above in studies on MRSA samples from 
hospitals in 06 provinces in that country (De Lencastre, 1997). The pediatric clone was 
isolated in large numbers in 1996-98 in Colombia, and it is also found in Argentina and 
Poland in 1994-98 and 1990-98 (Oliveira et al., 2002).  
The last of the large pandemic clones, referred to as EMRSA-16, is prevalent in hospitals in 
the United Kingdom, Mexico and Greece, in addition to being responsible for an outbreak in 
Sweden from 1997 to 2000 (Aires de Souza & De Lencastre, 2004). 
6. Epidemiology and MLST 
The MLST method was developed by Maiden et al. (1998) by the sequencing and analysis of 
the loci of eleven constitutive genes of Neisseria meningitidis, and it is presently applied in 
molecular epidemiology studies on various pathogens, among which are S. aureus and S. 
epidermidis. 
This methodology has been used in numerous studies on molecular epidemiology with 
good results due its good reproducibility, thus allowing for the detection of pandemic 
clones from circulating S. aureus and S. epidermidis samples. 
Geng et al. (2010) reported the presence of clone ST59-MRSA-IV in China in community 
samples isolated from 47 children with impetigo and abscesses. In Malaysia, a study on 36 
samples isolated from a hospital in Klang Valley for a five-month period reported a rate of 
83.3% of samples belonging to clone ST 239 SCCmec III (Neela et al., 2010). 
MLST has been used for studies in which circulating clones are identified in replacement of 
another already established clone. Sola et al. (2006) reported the emergence of a new clone 
identified as ST5 in hospitals in Cordoba, Argentina, in replacement of the Brazilian clone 
(ST239), which circulates in that region. In that study, 103 MRSA samples isolated from 
April to June 2001 and 31 MSSA samples isolated from 1999 to 2002 were used. 
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Previous studies have used MLST for comparison between samples and the prevalence 
between different pandemic clones. Campanille et al. (2009) analyzed 301 MRSA samples 
isolated from 19 Italian hospitals from 1990 to 2001. An increase of clone ST228, known as 
Italian clone, was observed from 2000 to 2007, conjointly with the decrease of clone ST247 
(Iberian clone) when compared to the 1990-1999 period.  
Clone ST228 is also associated with patients with cystic fibrosis. A study conducted on 93 
MRSA samples isolated from patients with that disease at a treatment center in Madrid, 
Spain, identified 15 different PFGE patterns.  A sample of each of these patterns was typed 
by MLST, with clone ST228 showing higher prevalence, with eight pulsetypes, followed by 
ST5, with two pulsetypes, and ST247, ST72 and ST255 with one pulsetype each (Molina et 
al., 2008).  
In addition to epidemiological studies in hospitals and the detection of these pandemic 
clones from MRSA samples, the MLST method has been used to detect the transmission of 
oxacillin-resistant samples from animal reservoirs to humans, including its detection in 
hospitals. Some studied have detected the presence of MRSA clones in swines, thus 
emphasizing the importance of such animals as reservoirs. Smith et al. (2009) reported the 
presence of ST398 samples in swines and farmers in the mid-western region of the United 
States, which suggests transmission between animals and their breeders. In Germany, 1,600 
swabs from swines from 40 farms were analyzed in a study where samples typed as ST398 
were also identified (Köck et al., 2009). 
MLST is usually used for detecting pandemic clones with good results. But this method can 
also be utilized for characterizing samples involved in hospital outbreaks.  
Peacock et al. (2002) compared the MLST and PFGE methods in a study conducted on 104 S. 
aureus samples isolated from nasal swabs from patients under renal therapy. The isolated 
samples were typed by the MLST and PFGE methods with a similar discriminatory power 
between the two techniques for identification of circulating samples in hospitals. 
Vindel et al. (2009) analyzed 463 S.aureus samples isolated from 145 Spanish hospitals in 
2006. In addition to MLST, several methodologies such as PFGE, spa typing, SCCmec 
characterization and agr typing were used. MLST showed good correlation with the 
methodologies used for detecting circulating samples, with applicability in localized 
nosocomial studies. 
The combination of the two molecular epidemiology techniques can increase discriminatory 
power for analysis of different clones. Cookson et al. (2007) reported that the combination of 
the MLST and SCCmec methods are more appropriate for multi-center studies. The authors 
analyzed MRSA samples from various European countries by means of PFGE, MLST, 
SCCmec analysis and spa typing.  
7. Vancomycin-resistant S. aureus (VRSA) 
Detection of oxacillin resistant staphylococci is important to guide therapies and also to 
avoid use of vancomycin, which is an antimicrobial agent with therapeutic complications, 
and can lead to selection of resistant strains. Acquired microbial resistance to vancomycin is 
a growing problem, in particular, within healthcare facilities such as hospitals.  The 
widespread use of vancomycin makes resistance to the drug a significant worry, especially 
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for individual patients if resistant infections are not quickly identified and the patient 
continues the ineffective treatment. Vancomycin-resistant Enterococcus (VRE) emerged in 
1987 and the transfer potential of such resistance to other bacteria, vancomycin resistance 
surveillance has been an object of great scientific interest worldwide.  Vancomycin 
resistance emerged in more common pathogenic organisms during the 1990s and 2000s, 
including vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant 
Staphylococcus aureus (VRSA). 
In 1996, the first clinical S. aureus isolate with reduced vancomycin sensitivity, with MIC 
value in the intermediate range (MIC = 8 g/ml) and referred to as VISA was reported in 
Japan (Hiramatsu et al. 1997). Additionally, in June 2002 [44], eight patients with infections 
caused by S. aureus with reduced vancomycin sensitivity were confirmed in the United 
States. One month later, the Centers for Disease Control and Prevention (CDC) published 
the first reported on vancomycin-resistant S. aureus (VRSA, with MIC = or  32 g/ml) in a 
patient in Michigan, United States. The sample isolated from the patient contained the vanA 
gene as well as the mecA gene for oxacillin resistance. The presence of the vanA gene in this 
VRSA suggests that resistance may have been acquired through the passage of genetic 
material from vancomycin-resistant enterococci to S. aureus. In October of the same  
year [44], the second clinical isolate of VRSA was reported in a patient in Pennsylvania. The 
VRSA isolate also contained the vanA and the mecA genes. The presence of the vanA  
gene suggests that the resistance determinant was acquired from vancomycin-resistant 
Enterococcus isolated from the same patient. April 2004, the third VRSA isolated from a 
patient in New York was reported. The isolate also contained the oxacillin- and vancomycin-
resistance mecA and vanA genes, respectively. According to CDC, the three VRSA isolated 
did not seem to be epidemiologically related (CDC 2002; CDC 2004). The CDC (2010)  
has recently confirmed the 11th case of vancomycin resistant Staphylococcus aureus  
(VRSA) infection since 2002 in the United States (Table 2).  This serves as a reminder about the  
 
Case State Year Age Source 
1 Michigan 2002 40 Plantar ulcers & 
Catheter tip 
2 Pennsylvania 2002 70 Plantar ulcer 
3 New York 2004 63 Urine from a 
nephrostomy tube 
4 Michigan 2005 78 Toe wound 
5 Michigan 2005 58 Surgical site wound 
after panniculectomy 
6 Michigan 2005 48 Plantar ulcer 
7 Michigan 2006 43 Triceps wound 
8 Michigan 2007 48 Toe wound 
9 Michigan 2007 54 Surgical site wound 
after foot amputation 
10 Michigan 2009 53 Plantar foot wound 
11 Delaware 2010 64 Wound drainage 
Source: CDC (2010) 
Table 2. Vancomycin resistant Staphylococcus aureus (VRSA) infection in the United States 
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important role of clinical laboratories in the diagnosis of VRSA cases to ensure prompt 
recognition, isolation, and management by infection control personnel. Appropriate 
antimicrobial prescribing by healthcare providers, adherence to recommended infection 
control guidelines, and, ultimately, the control of both MRSA and VRE are necessary to 
prevent further emergence of VRSA strains. 
8. Conclusions and perspectives 
Given the high rates of oxacillin resistance reported in various countries and the 
emergence of vancomycin-resistant MRSA samples, further detailed studies on the 
characteristics of circulating strains in hospitals and the characterization of clones 
prevailing in larger regions are necessary since the different MRSA clones vary in 
virulence and antimicrobial resistance. The molecular epidemiology methods are useful 
tools in these types of study, and the MLST technique is especially useful due to its 
versatility, easy performance and high reproducibility, with applications in localized 
studies, such as in the characterization of outbreaks and in the detection of circulating 
clones in large regions. 
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